Vocal cord palsy in refractory anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis

Rheumatology (Oxford). 2020 Oct 1;59(10):e66-e67. doi: 10.1093/rheumatology/keaa130.

Authors

Omar Suhail Alsaed¹, Laith Ishaq Alamlih¹, Khalifa Abdulsalam Farfar², Tasleem Raza N Mohd³, Samar A Al Razaq Alemadi¹, Hani Ali Malallah¹

Affiliations

¹ Department of Medicine, Division of Rheumatology, Hamad Medical Corporation, Doha.
² Department of Medicine, Division of Respirology, Hamad Medical Corporation, Alwakra Hospital, Alwakra.
³ Department of Medicine, Division of Respirology, Hamad Medical Corporation, Doha, Qatar.

PMID: 32252065
DOI: 10.1093/rheumatology/keaa130

No abstract available

Publication types

Case Reports

MeSH terms

Autoantibodies / immunology*
Deglutition Disorders / etiology
Dermatomyositis / complications
Dermatomyositis / diagnosis
Dermatomyositis / immunology*
Dermatomyositis / pathology
Drug Therapy, Combination
Dysphonia / etiology
Fatal Outcome
Glucocorticoids / administration & dosage
Glucocorticoids / therapeutic use
Humans
Immunoglobulins, Intravenous / therapeutic use
Interferon-Induced Helicase, IFIH1 / antagonists & inhibitors*
Lung Diseases, Interstitial / diagnostic imaging
Lung Diseases, Interstitial / pathology
Male
Methylprednisolone / administration & dosage
Methylprednisolone / therapeutic use
Middle Aged
Tomography, X-Ray Computed / methods
Vocal Cord Paralysis / diagnosis
Vocal Cord Paralysis / etiology*

Substances

Autoantibodies
Glucocorticoids
Immunoglobulins, Intravenous
Interferon-Induced Helicase, IFIH1
Methylprednisolone